The SCID-hu mouse: an in vivo model for HIV-1 infection in humans
- PMID: 9211415
- DOI: 10.1016/s1357-4310(97)01046-0
The SCID-hu mouse: an in vivo model for HIV-1 infection in humans
Abstract
The lack of suitable animal models for the in vivo study of HIV-1 infection has prompted investigators to take advantage of the graft-rejection deficit in severe combined immunodeficient (SCID) mice. Two separate approaches have been used to transplant human lymphoid and/or hemolymphoid tissues into SCID mice to generate chimeric animals in which distinct elements of the human immune system could be maintained and studied in vivo. The two models that arose from this work were the SCID-hu mouse and hu-PBL-SCID mouse. The goal of producing these distinct models is to provide an easily manipulable model for the in vivo analysis of HIV-1 infection and its ensuing pathophysiology. Both models support HIV-1 replication and display potential as models for studying antiviral strategies and mechanisms of viral pathogenesis. This review focuses on the SCID-hu mouse.
Similar articles
-
Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: an in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues.Antimicrob Agents Chemother. 1997 Sep;41(9):1880-7. doi: 10.1128/AAC.41.9.1880. Antimicrob Agents Chemother. 1997. PMID: 9303378 Free PMC article.
-
Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver.Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3126-31. doi: 10.1073/pnas.93.7.3126. Proc Natl Acad Sci U S A. 1996. PMID: 8610180 Free PMC article.
-
Construction of human-SCID chimeric mice.Curr Protoc Immunol. 2001 May;Chapter 4:4.8.1-4.8.17. doi: 10.1002/0471142735.im0408s25. Curr Protoc Immunol. 2001. PMID: 18432798
-
HIV-1-associated pathology in hemato-lymphoid organs and the experimental evaluation in the SCID-hu mouse.Int J Hematol. 1996 Jun;63(4):253-64. doi: 10.1016/0925-5710(96)00452-5. Int J Hematol. 1996. PMID: 8762809 Review.
-
The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS.Semin Immunol. 1996 Aug;8(4):215-21. doi: 10.1006/smim.1996.0027. Semin Immunol. 1996. PMID: 8883144 Review.
Cited by
-
Role of the ubiquitin system and tumor viruses in AIDS-related cancer.BMC Biochem. 2007 Nov 22;8 Suppl 1(Suppl 1):S8. doi: 10.1186/1471-2091-8-S1-S8. BMC Biochem. 2007. PMID: 18047745 Free PMC article. Review.
-
Variable region 4 of SIV envelope correlates with rapid disease progression in morphine-exposed macaques infected with SIV/SHIV.Virology. 2007 Feb 20;358(2):373-83. doi: 10.1016/j.virol.2006.08.039. Epub 2006 Sep 28. Virology. 2007. PMID: 17011009 Free PMC article.
-
Human cytomegalovirus genes in the 15-kilobase region are required for viral replication in implanted human tissues in SCID mice.J Virol. 2005 Feb;79(4):2115-23. doi: 10.1128/JVI.79.4.2115-2123.2005. J Virol. 2005. PMID: 15681414 Free PMC article.
-
HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model.Retrovirology. 2013 Oct 24;10:121. doi: 10.1186/1742-4690-10-121. Retrovirology. 2013. PMID: 24156277 Free PMC article.
-
Humanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1.PLoS One. 2012;7(6):e38853. doi: 10.1371/journal.pone.0038853. Epub 2012 Jun 13. PLoS One. 2012. PMID: 22719966 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical